Examining Genetic Factors That Affect the Severity of 22q11.2 Deletion Syndrome

Part of paid clinical trials in New York, New York.

Sponsor
Albert Einstein College of Medicine
Study ID
NCT00556530
Status
Recruiting
Apply to this trial

Conditions

  • 22q11.2 Deletion Syndrome
  • DiGeorge Syndrome

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Study Details

22q11.2 deletion syndrome is a genetic disorder that can cause heart defects, facial abnormalities, and developmental and learning disabilities. The severity of the disorder can vary widely among people. This study will analyze DNA from people with 22q11.2 deletion syndrome to identify genetic variations that may affect the severity of the disorder.

Key Dates

First listed
Nov 12, 2007
Start date
Jul 31, 2016
Status verified
Jul 2025
Primary completion
Jun 30, 2029
Completion
Jun 30, 2029

Study Design

Enrollment
1,000 participants (estimated)

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Albert Einstein College of MedicineNew YorkNew York10461
Bernice E. Morrow, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in New York, NY

By research site
Albert Einstein College of Medicine· New York, NY

Related Studies